Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers

Epidemiology and Infection

Volumn 117, Issue 2, 1996, Pages 343-348

  Taylor, M B ^a   Parker, S P ^b   Crewe Brown, H H ^c   McIntyre, J ^d   Cubitt, W D ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

AGGLUTINATION TEST; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; SEROEPIDEMIOLOGY; SOUTH AFRICA; T CELL LEUKEMIA;

EID: 0029958025     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268800001527     Document Type: Article

References (46)

1. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-80.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031-5.
3. Gessain A, Vernant JC, Maurs L, et al. Antibodies to human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet 1985; ii: 407-9.
4. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; i: 1031-2.
5. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type 1 and adult T-cell leukemia-like cells. Ann Neurol 1987; 21: 117-22.
6. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-1 uveitis: a distinct clinical entity. Jpn J Cancer Res 1992; 83: 236-9.
7. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336: 1345-7.
8. Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-1I). Ann Int Med 1993; 118: 448-54.
9. Tajima K, the T- and B-cell Malignancy Study Group and Co-authors. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographic and clinical features. Int J Cancer 1990; 45: 237-43.
10. Yamaguchi K. Human T-lymphotropic virus type 1 in Japan. Lancet 1994; 343: 213-6.
11. Blattner WA, Blayney DW, Robert-Guroff M, et al. The human type-C retrovirus, HTLV, in blacks from the Caribbean, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982; 30: 257-64.
12. Saxinger W, Blattner WA, Levine PH, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 184; 225: 1473-6.
13. De Thé G, Gessain A, Gazzolo L, et al. Comparative seroepidemiology of HTLV-I and HTLV-II in the French West Indies and some African countries. Cancer Res 1985; 45: 4633s-6s.
14. Jeannel D, Garin B, Kazadi K, Singa L, de Thé G. The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaïre. J AIDS; 6: 840-4.
15. Bhigjee AI, Vinsen C, Windsor IM, Gouws E, Bill PLA, Tait D. Prevalence and transmission of HTLV-I infection in Natal/Kwazulu. S Afr Med J 1993; 83: 665-7.
16. Garin B, Gosselin S, de Thé G, Gessain A. HTLV-I/II infection in a high endemic area of Zaire, Central Africa: Comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern. J Med Virol 1994; 44: 104-9.
17. Blayney DW, Blattner WA, Robert-Guroff M, et al. The human T-cell leukemia-lymphoma virus (HTLV) in the southeastern United States. JAMA 1983; 250: 1048-52.
18. Greaves MF, Verbi W, Tilley R, et al. Human T-cell leukaemia virus (HTLV) in the& United Kingdom. Int J Cancer 1984; 33: 795-806.
19. Nightingale S, Orton D, Ratcliffe D, Skidmore S, Tosswill J, Desselberger U. Antenatal survey for the seroprevalence of HTLV-I infections in the West Midlands, England. Epidemiol Infect 1993; 110: 379-87.
20. Bhigjee AI, Kelbe C, Haribhai HC, et al. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in Natal, South Africa. A clinical and investigative study in 24 patients. Brain 1990; 113: 1307-20.
21. Joubert J, van As AD, Lecatsas G, Bos P. Human T-lymphotropic virus type I-associated myelopathy. A case report. S Afr Med J 1991; 80: 592-3.
22. Jogessar VB, de Bruyn CC, Bhigjee AI, Naicker VL, Bill PLA, Tait D. Adult T-cell leukaemia/lymphoma associated with HTLV-I in Natal. S Afr Med J 1992; 81: 528-9.
23. Patel M, Stevens W, Crewe-Brown HH, et al. Adult T-cell leukaemia/lymphoma: A case report. South Afr J Epidemiol Infect 1995; 10: 6-7.
24. Becker WB, Becker MLB, Homma T, Brede HD, Kurth R. Serum antibodies to human T-cell leukaemia virus type I in different ethnic groups and in non-human primates in South Africa. S Afr Med J 1985; 67: 445-9.
25. Botha MC, Jones M, de Klerk WA, Yamamoto N. Distribution and possible spread of human T-cell leukaemia virus type I in human communities in the northern and eastern Transvaal. S. Afr Med J 1985; 67: 668-71.
26. Lecatsas G, Joubert JJ, Schutte CHJ, Taylor MB, Swanevelder C. HTLV-I seropositivity in East Caprivi, SWA/Namibia. S Afr Med J 1988; 74: 643-4.
27. Neill AGS, Fernandes-Costa FJTD. Anti HTLV-I in blood donors in Natal. S Afr Med J 1990; 78: 376.
28. Taylor MB, Janse van Rensburg E, Swanevelder C, Carlier ND, Glatthaar E. HIV and HTLV-I survey in Venda. S Afr Med J 1992; 81: 485.
29. Bhigjee AI, Thaler D, Madurai S, Gouws E, Bill PLA. Seroprevalence of HTLV-I in Natal/KwaZulu. S Afr Med J 1994; 84: 368.
30. Maaga S, Steele AD, Bos P, Lecatsas G. HTLV-I infection in Bushmen at Schmidtsdrift. South Afr J Epidemiol Infect 1994; 9: 67-8.
31. Maaga S, Steele AD, Aspinall S, Lecatsas G. A seroepidemiological survey of HTLV-I and -II in STD clinic attendees and a healthy population group in Gauteng, South Africa. South Afr J Epidemiol Infect 1995; 10: 56-9.
32. Van der Ryst E, Smith MS. A high seroprevalence of HTLV-I antibodies in HIV-1 seropositive patients with neurologic disease. South Afr J Epidemiol Infect 1994; 9: 20-3.
33. Ades AE, Parker S, Berry T, et al. Prevalence of maternal HIV-1 infection in Thames Regions: results from anonymous unlinked neonatal testing. Lancet 1991; 337: 1562-5.
34. Department of Health. National HIV surveys in South Africa. Epidemiol Comments 1994; 21: 229.
35. Department of Health. The New South Africa. Epidemiol Comments 1994; 21: 94-7.
36. Department of Health. Fifth national HIV survey in women attending antenatal clinics of the public health services in South Africa. Epidemiol Comments 1995; 22: 90-100.
37. Crewe-Brown HH, Modi G, Khoosal M, et al. Symptomatic HTLV-I infection at Baragwanath Hospital, South Africa. Prague, Czeck Republic: Abstracts of the 6th International Congress for Infectious Diseases, 1994: 221.
38. Peckham CS, Tedder RS, Briggs M, et al. Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet 1990; 335: 516-9.
39. Parker SP, Taylor MB, Ades AE, Cubitt WD, Peckham C. Detection and confirmation of HTLV-I specific antibodies in dried blood spots for epidemiological studies. J Clin Pathol 1995; 48: 904-7.
40. Centers for Disease Control. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989; 38 (No. S-7): 1-7.
41. Noda S, Eizuru Y, Minamishima Y, Ikenoue T, Mori N. Detection of human T-cell lymphotropic virus type 1 infection by the polymerase chain reaction using dried blood specimens on filter papers. J Virol Methods 1993; 43: 111-22.
42. Yourno J. Direct polymerase chain reaction for detection of human immunodeficiency virus in blood spot residues on filter paper after elution of antibodies: an adjunct to serological surveys for estimating vertical transmission rates among human immunodeficiency virus antibody-positive newborns. J Clin Microbiol 1983; 31: 1364-7.
43. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1992; 18: 571-3.
44. Goubau P, Desmyter J, Swanson P, et al. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides. J Med Virol 1993; 39: 28-32.
45. 24 in healthy and diseased persons in SWA/Namibia. S Afr Med J 1984; 66: 515-6.
46. Becker WB, Botha MC, Engelbrecht S, Becker MLB. Isolation of human T-lymphotropic virus type I (HTLV-I) from a black South African with Kaposi's sarcoma. S Afr Med J 1988; 73: 481-3.